Developing a new therapeutic for the treatment of invasive aspergillosis
Ended Project Grant Awarded Last action
- Award ID
- R44AI106235
- Recipient
-
Amplyx Pharmaceuticals, Inc. UEI N4A8X52DCND5
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $1,476,417
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Place of performance
- San Diego, CA 92121, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$18,973 | |
| Amendment | $745,405 | |
| Original award | $749,985 |
Quick answers
Who received award R44AI106235?
R44AI106235 was awarded to Amplyx Pharmaceuticals, Inc. by National Institutes of Health (Department of Health and Human Services) on July 18, 2013.
How much is award R44AI106235 worth?
$1,476,417 has been obligated on R44AI106235.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award